Volume 9, Number 7—July 2003
Dispatch
Serologic Evidence of West Nile Virus Infection in Horses, Coahuila State, Mexico
Table
Horse | Study site | Clinical illness | % inhibition by ELISAb | cPRNT90 titer |
PRNT diagnosis | |
---|---|---|---|---|---|---|
WNV | SLEV | |||||
H-1 |
Ciudad Acuña |
No |
90 |
>320 |
—d |
WNV |
H-2 |
Ciudad Acuña |
No |
5 |
— |
— |
Negative |
H-3 |
Ciudad Acuña |
No |
0 |
— |
— |
Negative |
H-4 |
Ciudad Acuña |
No |
0 |
— |
— |
Negative |
H-5 |
Ciudad Acuña |
No |
90 |
>320 |
40 |
WNV |
H-6 |
Ciudad Acuña |
No |
93 |
>320 |
— |
WNV |
H-7 |
Ciudad Acuña |
No |
93 |
>320 |
— |
WNV |
H-8 |
Ciudad Acuña |
Yes |
93 |
>320 |
— |
WNV |
H-9 |
Ciudad Acuña |
Yes |
86 |
>320 |
— |
WNV |
H-10 |
Ciudad Acuña |
Yes |
90 |
>320 |
20 |
WNV |
H-11 |
Ciudad Acuña |
No |
89 |
>320 |
— |
WNV |
H-12 |
Ciudad Acuña |
No |
92 |
>320 |
20 |
WNV |
H-13 |
Ciudad Acuña |
Yes |
91 |
>320 |
— |
WNV |
H-14 |
Ciudad Acuña |
Yes |
78 |
>320 |
20 |
WNV |
H-15 |
Jiménez |
No |
82 |
>320 |
— |
WNV |
H-16 |
Jiménez |
No |
25 |
40 |
— |
WNV |
H-17 |
Jiménez |
No |
7 |
— |
— |
Negative |
H-18 |
Jiménez |
No |
93 |
>320 |
20 |
WNV |
H-19 |
Jiménez |
No |
0 |
20 |
20 |
Flavivirus |
H-20 |
Jiménez |
No |
47 |
40 |
— |
WNV |
H-21 |
Saltillo |
No |
9 |
— |
— |
Negative |
H-22 |
Saltillo |
No |
15 |
— |
— |
Negative |
H-23 |
Saltillo |
No |
12 |
— |
— |
Negative |
H-24 | Saltillo | No | 11 | — | — | Negative |
aELISA, enzyme-linked immunosorbent assay; PRNT, plaque reduction neutralization test; WNV, West Nile virus; SLEV, Saint Louis encephalitis virus.
bInhibition values >30% are considered significant.
cNeutralizing antibodies to WNV in selected horse serum samples were confirmed at Centers for Disease Control and Prevention-Division of Viral and Bacterial Infectious Diseases by PRNT.
d—, <20.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.